Sanofi Suit Triggers 30-Month Stay Of FDA Action On Barr’s Ambien CR ANDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi-Aventis filed a patent infringement suit against Barr on April 5 over the controlled release form of zolpidem.
You may also be interested in...
Generic Ambien To Launch Immediately Following FDA Approval
FDA approves the first generic versions of Sanofi-Aventis’ immediate-release zolpidem.
Generic Ambien To Launch Immediately Following FDA Approval
FDA approves the first generic versions of Sanofi-Aventis’ immediate-release zolpidem.
Changing Of The Seasonale: Barr’s Extended-Cycle Contraceptive Goes Generic
Company tries to hedge losses through “authorized” generic and follow-on Seasonique.